Herberg K W
TUV Rheinland e. V., Köln.
Fortschr Neurol Psychiatr. 1994 Sep;62 Suppl 1:24-8.
The influence of paroxetine (1x20 mg/day) on safety-relevant performance was compared with the effects of doxepin (2x50 mg/day) and placebo. The medication covered a 3-week period. On day 20 of treatment, ethanol was additionally administered (0.05% BAC). The study group comprised 60 healthy male and female volunteers in the age range 37-60 years, who were assigned to the three structurally identical medication groups under randomized, double-blind conditions. The functional capacity of primary interest was investigated in seven tests to record visual orientation, forced concentration, simple reaction time, choice reaction time, reaction under stress, vigilance, and motor co-ordination. Test sessions took place before the treatment and five times during the medication phase. Paroxetine proved comparable to placebo in all cases, while in comparison with the two reference substances doxepin revealed loss of vigilance and motor coordination, as well as of concentration and the simple (acoustic) reaction time.
将帕罗西汀(每日1次,每次20毫克)对安全相关行为表现的影响与多塞平(每日2次,每次50毫克)及安慰剂的效果进行了比较。药物治疗为期3周。在治疗的第20天,额外给予乙醇(血液酒精浓度0.05%)。研究组由60名年龄在37至60岁之间的健康男性和女性志愿者组成,他们在随机、双盲条件下被分配到三个结构相同的药物治疗组。通过七项测试来研究主要关注的功能能力,以记录视觉定向、强制注意力、简单反应时间、选择反应时间、应激反应、警觉性和运动协调性。测试在治疗前进行,在药物治疗阶段进行了五次。在所有情况下,帕罗西汀被证明与安慰剂相当,而与两种对照物质相比,多塞平显示出警觉性、运动协调性、注意力以及简单(听觉)反应时间的下降。